Maurizio Zangari Selected Research

Maurizio Zangari Research Topics

Disease

81	Multiple Myeloma 04/2024 - 03/2002
18	Neoplasms (Cancer) 10/2023 - 06/2003
9	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 12/2002
7	Thrombosis (Thrombus) 04/2013 - 06/2003
6	Venous Thromboembolism 11/2012 - 08/2006
5	Infections 03/2024 - 03/2003
5	Activated Protein C Resistance (APC Resistance) 11/2012 - 06/2003
4	Paraproteinemias (Monoclonal Gammopathy) 11/2022 - 06/2007
4	Disease Progression 02/2021 - 01/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 03/2006 - 08/2002
3	Bone Diseases (Bone Disease) 10/2023 - 01/2009
2	Agammaglobulinemia (Hypogammaglobulinemia) 08/2023 - 07/2023
2	Smoldering Multiple Myeloma 02/2021 - 09/2015
2	Hematologic Neoplasms (Hematological Malignancy) 11/2018 - 01/2015
2	Bone Resorption 05/2016 - 01/2009
2	Pain (Aches) 03/2010 - 04/2003
2	Thrombophilia 07/2009 - 06/2003
2	Monoclonal Gammopathy of Undetermined Significance 02/2007 - 01/2002
2	Headache (Headaches) 01/2004 - 04/2003
1	Hyperferritinemia 03/2024
1	Anemia 02/2024
1	Thrombocytopenia (Thrombopenia) 02/2024
1	Lymphopenia (Lymphocytopenia) 08/2023
1	Neutropenia 07/2023
1	Residual Neoplasm 01/2022
1	Genetic Translocation (Chromosomal Translocation) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022
1	Carcinogenesis 01/2020
1	Bacteremia 04/2019
1	Altitude Sickness (Mountain Sickness) 04/2013
1	Polycythemia Vera 04/2013
1	Viremia 11/2012
1	Adenocarcinoma 03/2010

Drug/Important Bio-Agent (IBA)

16	Thalidomide (Thalomid)FDA Link 12/2023 - 04/2002
16	Bortezomib (Velcade)FDA Link 12/2023 - 10/2005
9	Melphalan (Alkeran)FDA LinkGeneric 12/2023 - 03/2002
7	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023 - 03/2003
6	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2024 - 01/2023
5	Chimeric Antigen ReceptorsIBA 02/2024 - 01/2022
5	Immunomodulating AgentsIBA 01/2016 - 12/2002
4	Lenalidomide (CC 5013)FDA Link 12/2023 - 10/2007
4	Monoclonal AntibodiesIBA 01/2022 - 06/2015
4	Proteins (Proteins, Gene)FDA Link 05/2016 - 01/2010
3	Bispecific AntibodiesIBA 08/2023 - 01/2022
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 06/2003
3	Proteasome InhibitorsIBA 05/2016 - 04/2014
3	CytokinesIBA 11/2012 - 06/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 04/2003
3	Protein CIBA 07/2011 - 06/2003
3	Alkaline PhosphataseIBA 06/2011 - 10/2005
3	Hemostatics (Antihemorrhagics)IBA 08/2008 - 06/2007
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2007 - 09/2004
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2024 - 07/2023
2	B-Cell Maturation AntigenIBA 03/2024 - 01/2024
2	Etoposide (VP 16)FDA LinkGeneric 12/2023 - 06/2003
2	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 06/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 06/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 06/2003
2	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2022
2	daratumumabIBA 08/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2020 - 11/2018
2	ParaproteinsIBA 09/2018 - 03/2007
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018 - 05/2016
2	Parathyroid Hormone (Parathormone)IBA 01/2018 - 04/2014
2	AutoantibodiesIBA 11/2012 - 06/2003
2	CreatinineIBA 01/2010 - 07/2007
2	Antineoplastic Agents (Antineoplastics)IBA 10/2009 - 08/2005
2	AnticoagulantsIBA 08/2008 - 03/2007
2	Biomarkers (Surrogate Marker)IBA 02/2007 - 09/2006
2	factor V LeidenIBA 08/2006 - 06/2003
1	Immunoglobulin D (IgD)IBA 04/2024
1	Transferrin (beta 2 Transferrin)IBA 03/2024
1	Hemoglobins (Hemoglobin)IBA 02/2024
1	Cystatin MIBA 10/2023
1	NIMA-Related KinasesIBA 10/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	tisagenlecleucelIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 02/2021
1	Busulfan (Busulfex)FDA Link 12/2019
1	CollagenIBA 11/2018
1	UbiquitinIBA 05/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	AlbuminsIBA 09/2015
1	SaltsIBA 04/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Thromboplastin (Tissue Factor)IBA 11/2012
1	Factor V (Coagulation Factor V)IBA 07/2011
1	Viper Venoms (Viper Venom)IBA 07/2011
1	carfilzomibIBA 06/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2010

Therapy/Procedure

40	Therapeutics 02/2024 - 06/2002
15	Drug Therapy (Chemotherapy) 03/2022 - 08/2002
6	Stem Cell Transplantation 03/2022 - 01/2016
6	Transplantation 01/2022 - 01/2002
4	Autologous Transplantation 04/2008 - 05/2003
3	Hematopoietic Stem Cell Transplantation 12/2023 - 03/2006
2	Aftercare (After-Treatment) 01/2022 - 06/2002
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2012 - 08/2012
2	Homologous Transplantation 01/2003 - 03/2002